Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 36 Carcinoma, Non-Small-Cell Lung 17 Small Cell Lung Carcinoma 16 Neoplasms 14 Lung Neoplasms 13 Breast Neoplasms 7 Melanoma 6 Colorectal Neoplasms 6 Carcinoma, Renal Cell 6 Liver Neoplasms 5 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Prostatic Neoplasms 4 Neoplasm Metastasis 4 Head and Neck Neoplasms 4 Glioblastoma 4 Endometrial Neoplasms 4 Sarcoma 3 Recurrence 3 Neoplasms by Site 3 Neoplasms by Histologic Type 3 Carcinoma, Transitional Cell 3 Uterine Cervical Neoplasms 2 Urogenital Neoplasms 2 Small Cell Lung Cancer Extensive Stage 2 Sarcoma, Alveolar Soft Part 2 Ovarian Neoplasms 2 Osteosarcoma 2 Mesothelioma, Malignant 2 Mesothelioma 2

Interventions

tocilizumab 1 atezolizumab 1 Tiragolumab 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Advanced Liver Cancers × atezolizumab × Clear all

NCT04524871 2026-05-22

MORPHEUS-LIVER

Hoffmann-La Roche

Phase 1/2 Recruiting

Advanced Liver Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡